Leadless Pacemakers Market : Global Demand Analysis & Opportunity Outlook 2024

Leadless Pacemakers Market Overview

Leadless pacemakers are medical devices which are used for the treatment of patients suffering from heart related diseases such as brady-arrythmias and slow heart rhythms. These are complete enclosed capsules which include pacemaker electronics and power source. Further, leadless pacemakers are implantable devices transplanted directly in the right ventricle of the heart where it sends small electrical impulses to the heart muscles to continue at an acceptable heart rate. Additionally, leadless pacemakers are less invasive as compared to traditional pacemakers and can be implanted within an hour. Leadless pacemakers take less time to recover and also eliminate problems related to transvenous leads such as lead fracture, insulation breaks and other. Leadless pacemakers produce comparatively less radiation and have better life quality without causing any infection to the heart ventricle.

Market Size & Forecast

The global leadless pacemakers market is expected to witness a robust growth over the forecast period i.e. 2017-2024. Rising heart related diseases across the globe and rising adoption of highly advanced medical devices in healthcare sector is envisioned to foster the growth of global leadless pacemakers market during the forecast period.

In terms of region, global leadless pacemakers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Among these regions, North America is the biggest market in leadless pacemakers and is anticipated to witness a robust growth over the forecast period owing to factors such as rising number of people suffering from heart related diseases and growing adoption of leadless pacemakers in healthcare sector in this region. In United States of America alone, more than 70% pacemakers’ implantations have been done in recent past. Further, North America region is expected to behold this positive growth over the forecast period.

Asia Pacific region is projected to witness a remarkable growth over the forecast period owing to factors such as development of new medical industries and increasing investment in healthcare sector in this region. Additionally, factors such as rapid advancement in healthcare infrastructure and medical sector in Europe region is expected to drive the growth of leadless pacemakers market in this region.

Market Segmentation

Our-in depth analysis of the global leadless pacemakers market includes the following segments:

By Technology

• Micra Transcatheter Pacing System
• Nanostim Leadless Pacemakers
• Wireless Cardiac Simulation System

By Region

Global leadless pacemakers market is further classified on the basis of region as follows:

• North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
• Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
• Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.
• Middle East and Africa (GCC, North Africa, South Africa and Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis.

Growth Drivers & Challenges

Global leadless pacemakers market is primarily driven by factors such as rising number of individuals suffering from heart related diseases such as bradycardia and others. Additionally, rapid failure of conventional pacemakers is also propelling the demand for leadless pacemakers which are comparatively effective in heart related diseases.

Further, additional advantages with implementation of leadless pacemakers such as lack of lead related complications and avoidances of pocket related problems such as infection, disfigurement and elimination of lead fracture are some of the major factors which are driving the growth of global leadless pacemakers market. Moreover, leadless pacemakers offer more convenience including less implementation time (less than an hour), less invasive and less recovery time. Such factors are expected to propel the demand for leadless pacemakers in healthcare sector.

However, high cost of leadless pacemakers (more than ten times of conventional pacemakers) may dampen the growth of global leadless market in near future.

Key Players

• Medtronics
  • Company Overview
  • Key Product Offerings
  • Business Strategy
  • SWOT Analysis
  • Financial
• St. Jude Medical LLC (Abbott Laboratories)
• Biotronic

Some other prominent vendors that may enter into manufacturing of leadless pacemaker are:

• Boston Scientific
• Edwards Lifesciences
• Sorin Group
• Vitatron
• Lepu Medical
• Terumo Corp.

Scope & Context

Overview of the Parent Market

Analyst View

Segmentation

The global leadless pacemakers market is segmented as follows:

• By Technology Market Size & Y-O-Y Growth Analysis
• By Chamber Market Size & Y-O-Y Growth Analysis
• By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment